Dr. Ling's research interests center on hypothesis driven, big data empowered, translational discovery, particularly:

• The implementation and use of “big data” based medicine and data analysis in complex health care settings for improved cost and care effectiveness.
• Mulit-omics (genomics and proteomics focused) analyses of gene/protein biomarkers for the diagnosis and prognosis of the inflammatory entity of Necrotizing Enterocolitis (NEC), sepsis in premature infants, Kawasaki disease, CNS cancer metastasis, and women preganancy preterm diseases.
• Precision medicine – development of novel computational analysis for NGS analysis and NGS based disease diagnostics integrating vast amount of public domain NGS genomic resources.
• Clinical sensor – development of novel chemical based sensor technologies to allow urine based diagnostics.